Cardax (OTCQB: CDXI) is developing proprietary astaxanthin therapies for large unmet medical needs where oxidative stress and inflammation play important causative roles.
Charlie Health
15 followers
PharmaForce
1 follower
Bristol-Myers Squibb
316 followers
Viatris
53 followers
Lundbeck
52 followers
Alnylam Pharmaceuticals
50 followers
NYU Langone Health
49 followers
Syneos Health
38 followers
Omnicell
32 followers
Organon
29 followers
Prescient Healthcare Group
29 followers
Parexel
21 followers